experience with i-o therapies in second-line nsclc
Published 6 years ago • 30 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
5:58
continuing/re-challenging with i-o therapy in nsclc
-
10:49
second-line treatment in nsclc
-
5:18
nsclc management: second-line options
-
7:21
second- & third-line options after chemotherapy or i/o
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc
-
7:34
varied timing of io therapy in patients with stage iii nsclc
-
4:30
case 3: second-line therapy after chemo/i-o in stage iv nsclc
-
1:37:58
siop 2024: educational: novel therapeutic approaches to high risk b-all
-
3:59
second-line treatment for nondriver metastatic nsclc
-
5:56
combination approaches for second-line therapy for nsclc
-
7:26
personal use of i-o therapy in advanced-stage nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
8:55
choosing second-line therapy for alk nsclc
-
5:24
treating relapsed/refractory nsclc after i-o therapy
-
7:35
i-o therapy versus surgery or chemotherapy in nsclc
-
5:51
the potential for io use as maintenance therapy in nsclc - o
-
5:06
early experience; immunotherapy chemotherapy for nsclc
-
1:27
dr. kelly on determining second-line tki in lung cancer
-
3:30
trials of i-o therapy in driver mutation nsclc